Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older

WEDNESDAY, Dec. 20, 2023 -- For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news